SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is experiencing strong momentum as investors anticipate the upcoming pancreatic cancer data presentation at Digestive Disease Week, which serves as a major catalyst for the stock. Community members are actively discussing the company's clinical progress, recent trial expansions, and the expectation that these milestones will drive the share price significantly higher.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending due to a combination of a significant pipeline update regarding its CUE-401 autoimmune candidate and a fresh milestone payment from its partnership with Boehringer Ingelheim. The community is actively debating the company's long-term pivot toward autoimmune therapies under new leadership, while traders weigh the impact of potential financial restructuring against the stock's recent volatility.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is experiencing intense selling pressure following a disappointing quarterly report that featured lowered forward bookings guidance and engagement concerns, leaving the community deeply divided over its long-term viability. While some investors are aggressively buying the dip, citing user growth potential and strong cash flow, critics are actively shorting the stock, citing ongoing regulatory scrutiny regarding child safety and lackluster profitability.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is facing intense market volatility following a blowout earnings report that shattered expectations, yet triggered a sell-the-news reaction as investors digest the stock's massive year-to-date rally. The community is actively debating the sustainability of this growth, with many focused on a newly announced share buyback program as a sign of management's confidence in an undervalued stock, while others warn of potential exhaustion after a parabolic move.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing significant movement and heavy community discussion as investors anticipate a major earnings print, with many debating whether the companys monetization of user data and community engagement will lead to a breakout or a post-earnings sell-off. Bulls are highlighting recent top and bottom-line growth as evidence of a maturing ad engine, while bears remain focused on potential user growth stagnation and the volatile historical reaction to the stock's previous quarterly results.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing a parabolic rally driven by a micro-float and extreme short squeeze conditions, with borrowing fees near 1000% fueling retail excitement. The community is actively debating the stock's potential to reach triple digits, while cautioning that the lack of fundamental catalysts creates a highly volatile environment prone to rapid corrections.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is seeing heavy community debate following a robust quarterly report that featured record revenue and a massive share buyback, even as some investors question the stock's valuation and the upcoming leadership transition to John Ternus. Traders are actively analyzing the company's forward guidance and the potential impact of rising memory costs on future margins.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics Holdings is facing significant downward pressure and intense community scrutiny following the announcement of an 80 million dollar common stock and pre-funded warrant offering. Investors are actively debating the necessity of this dilution, with many expressing deep frustration over the company's capital management, leadership performance, and the threat of another potential reverse split.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is attracting significant investor attention following a powerful earnings report where it beat revenue expectations and raised guidance, highlighting the success of its AI-driven Athena platform. The community is actively debating the stock's potential for a short squeeze and its long-term growth prospects, with many bulls emphasizing its consistent beat-and-raise history as evidence of strong operational execution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently seeing heightened volatility and intense community debate as the stock faces downward pressure despite significant AI-driven capital expenditure trends across the tech sector. Investors remain divided, with some pointing to competition from custom silicon and market manipulation, while others view the pullback as a buying opportunity given the company's entrenched role in the AI hardware stack.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tango Therapeutics (NASDAQ:TNGX) Trading Down 9.7% - Here's What Happened

Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 9.7% - What's Next...

Stifel Nicolaus Issues Positive Forecast for Tango Therapeutics (NASDAQ:TNGX) Stock Price

Stifel Nicolaus increased their price target on shares of Tango Therapeutics from $24.00 to $40.00 and gave the company a "buy" rating in a report on Monday...

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Rating of "Moderate Buy" by Brokerages

Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve research firms that are covering the firm, Marketbeat.com reports. One equities...

354,192 Shares in Tango Therapeutics, Inc. $TNGX Bought by Mass General Brigham Inc

Mass General Brigham Inc acquired a new position in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing...

Tango Therapeutics (NASDAQ:TNGX) Reaches New 1-Year High - Should You Buy?

Tango Therapeutics (NASDAQ:TNGX) Hits New 52-Week High - What's Next...

Tango Therapeutics (NASDAQ:TNGX) Insider Adam Crystal Sells 38,460 Shares

Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) insider Adam Crystal sold 38,460 shares of the business's stock in a transaction dated Wednesday, April 15th. The stock was sold at an average...

Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Insider Sells 38,460 Shares of Stock

Tango Therapeutics, Inc. (NASDAQ:TNGX - Get Free Report) insider Adam Crystal sold 38,460 shares of the company's stock in a transaction dated Wednesday, April 15th. The shares were sold at an...

Tudor Investment Corp ET AL Acquires New Holdings in Tango Therapeutics, Inc. $TNGX

Tudor Investment Corp ET AL acquired a new position in shares of Tango Therapeutics, Inc. (NASDAQ:TNGX - Free Report) in the 3rd quarter, according to its most recent filing with the Securities...

Tango Therapeutics (NASDAQ:TNGX) Reaches New 52-Week High  - Here's What Happened

Tango Therapeutics (NASDAQ:TNGX) Reaches New 52-Week High - Should You Buy...

<ul class="summary-bullets"><li>Revolution announced positive data from its own experimental cancer drug daraxonrasib in patients with metastatic pancreatic ductal adenocarcinoma, earlier in the day.&nbsp;</li><li>Erasca is focused on developing therapies for cancers like Revolution.</li><li>The company has several names in its pipeline for pancreatic cancer including ERAS-0015 and ERAS-4001.</li></ul>Shares of Erasca Inc. (ERAS) fell 7% on Monday on the heels of rival Revolution Medicines’s (RVMD) positive study data in pancreatic cancer, applauded as a “game changer” by Wall Street. &nbsp;Erasca is also focused on developing therapies for cancers, including pancreatic ductal adenocarcinoma (PDAC), like Revolution. The company has several names in its pipeline for pancreatic cancer, including ERAS-0015 and ERAS-4001.Last month, Erasca entered into a clinical trial collaboration and supply agreement with Tango Therapeutics, Inc. (TNGX) to evaluate ERAS-0015, with Tango’s vopimetostat, in pancreatic cancer.Revolution said earlier in the day that its late-stage trial evaluating its experimental cancer drug daraxonrasib in patients with metastatic pancreatic ductal adenocarcinoma, who had been previously treated, demonstrated statistically significant and clinically meaningful improvements in progression-free survival and overall survival compared with standard chemotherapy.Patients treated with the drug lived a median of 13.2 months, compared with 6.7 months for those on chemotherapy, highlighting a meaningful benefit. The treatment was also generally well tolerated, with no new safety concerns reported, the company said. RBC Capital now sees daraxonrasib in metastatic pancreatic ductal adenocarcinoma as a "game-changer."RVMD shares were up 41% at the time of writing.<h2 class="st-heading-2">Analyst Take Away</h2>Jefferies called Revolution’s results in second-line pancreatic ductal adenocarcinoma "a clear win" for daraxonrasib, but kept the bar for Erasca unchanged. The firm kept its ‘Buy’ rating and $21 price target on Erasca shares.According to data from Koyfin, eight of the 10 analysts covering ERAS stock rate it ‘Buy’ or higher, while one rates it ‘Hold’ and one rates it ‘Strong Sell.’ The average 12-month price target on the stock is $18.10, representing a potential upside of 14% from current trading levels.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around ERAS stock jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<a href="https://stocktwits.com/symbol/ERAS">ERAS stock</a> has gained nearly 1,200% over the past 12 months, compared to <a href="https://stocktwits.com/symbol/RVMD">RVMD</a>’s 272% rally.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/ima-stock-breaks-50dma-for-first-time-since-february/cZJ8drzRIur">IMA Stock Surges 24%, Breaks 50-DMA For First Time Since February – What's Driving The Rally?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Erasca logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

ERAS Stock Slumps Against RVMD Rally — Analyst Stays Bullish

Erasca is focused on developing therapies for cancers, including pancreatic ductal adenocarcinoma, like Revolution. 

Equity

Erasca is focused on developing therapies for cancers, including pancreatic ductal adenocarcinoma, like Revolution. 


Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.

TNGX
Tango Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TNGX News

TNGXTango Therapeutics Inc